NEFL and COVID-19: It is important to note that our putative biomarkers of disease progression in COVID-19 (IL6, CKAP4, Gal-9, IL-1ra, LILRB4 and PD-L1) were associated to NfL but to a much lesser extent to GFAP and tau.